Literature DB >> 15778955

Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen.

Edward Dolk1, Cees van Vliet, Janice M J Perez, Gert Vriend, Hervé Darbon, Gilles Ferrat, Christian Cambillau, Leon G J Frenken, Theo Verrips.   

Abstract

In a previous study we have shown that llama VHH antibody fragments are able to bind their antigen after a heat shock of 90 degrees C, in contrast to the murine monoclonal antibodies. However, the molecular mechanism by which antibody:antigen interaction occurs under these extreme conditions remains unclear. To examine in more detail the structural and thermodynamic aspects of the binding mechanism, an extensive CD, ITC, and NMR study was initiated. In this study the interaction between the llama VHH -R2 fragment and its antigen, the dye Reactive Red-6 (RR6) has been explored. The data show clearly that most of the VHH-R2 population at 80 degrees C is in an unfolded conformation. In contrast, CD spectra representing the complex between VHH-R2 and the dye remained the same up to 80 degrees C. Interestingly, addition of the dye to the denatured VHH-R2 at 80 degrees C yielded the spectrum of the native complex. These results suggest an induced refolding of denatured VHH-R2 by its antigen under these extreme conditions. This induced refolding showed some similarities with the well established "induced fit" mechanism of antibody-antigen interactions at ambient temperature. However, the main difference with the "induced fit" mechanism is that at the start of the addition of the antigen most of the VHH molecules are in an unfolded conformation. The refolding capability under these extreme conditions and the stable complex formation make VHHs useful in a wide variety of applications. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778955     DOI: 10.1002/prot.20378

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  26 in total

1.  Heat-induced irreversible denaturation of the camelid single domain VHH antibody is governed by chemical modifications.

Authors:  Yoko Akazawa-Ogawa; Mizuki Takashima; Young-Ho Lee; Takahisa Ikegami; Yuji Goto; Koichi Uegaki; Yoshihisa Hagihara
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

2.  Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function.

Authors:  Christophe Blanchetot; Dennis Verzijl; Azra Mujić-Delić; Leontien Bosch; Louise Rem; Rob Leurs; C Theo Verrips; Michael Saunders; Hans de Haard; Martine J Smit
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

3.  Construction of an artificially randomized IgNAR phage display library: screening of variable regions that bind to hen egg white lysozyme.

Authors:  Maki Ohtani; Jun-ichi Hikima; Tae Sung Jung; Hidehiro Kondo; Ikuo Hirono; Takashi Aoki
Journal:  Mar Biotechnol (NY)       Date:  2012-05-03       Impact factor: 3.619

4.  Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects.

Authors:  Jeroen A J M van de Water; Tugba Bagci-Onder; Aayush S Agarwal; Hiroaki Wakimoto; Rob C Roovers; Yanni Zhu; Randa Kasmieh; Deepak Bhere; Paul M P Van Bergen en Henegouwen; Khalid Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-25       Impact factor: 11.205

5.  An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface.

Authors:  Beatriz Álvarez; Kasper Krogh-Andersen; Christian Tellgren-Roth; Noelia Martínez; Gökçe Günaydın; Yin Lin; M Cruz Martín; Miguel A Álvarez; Lennart Hammarström; Harold Marcotte
Journal:  Appl Environ Microbiol       Date:  2015-06-19       Impact factor: 4.792

6.  Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.

Authors:  Daisuke Tokuhara; Beatriz Álvarez; Mio Mejima; Tomoko Hiroiwa; Yuko Takahashi; Shiho Kurokawa; Masaharu Kuroda; Masaaki Oyama; Hiroko Kozuka-Hata; Tomonori Nochi; Hiroshi Sagara; Farah Aladin; Harold Marcotte; Leon G J Frenken; Miren Iturriza-Gómara; Hiroshi Kiyono; Lennart Hammarström; Yoshikazu Yuki
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

7.  Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase.

Authors:  Katja Conrath; Alice S Pereira; Carlos E Martins; Cristina G Timóteo; Pedro Tavares; Silvia Spinelli; Joerg Kinne; Christophe Flaudrops; Christian Cambillau; Serge Muyldermans; Isabel Moura; Jose J G Moura; Mariella Tegoni; Aline Desmyter
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

8.  Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.

Authors:  P B A A van Driel; J R van der Vorst; F P R Verbeek; S Oliveira; T J A Snoeks; S Keereweer; B Chan; M C Boonstra; J V Frangioni; P M P van Bergen en Henegouwen; A L Vahrmeijer; C W G M Lowik
Journal:  Int J Cancer       Date:  2013-12-12       Impact factor: 7.396

9.  Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin.

Authors:  Daniel J Barrera; Julian N Rosenberg; Joanna G Chiu; Yung-Nien Chang; Michelle Debatis; Soo-Mun Ngoi; John T Chang; Charles B Shoemaker; George A Oyler; Stephen P Mayfield
Journal:  Plant Biotechnol J       Date:  2014-09-17       Impact factor: 9.803

Review 10.  Biotechnological applications of recombinant single-domain antibody fragments.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2011-06-09       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.